These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36342287)

  • 21. Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem.
    Tran-Dinh A; Neulier C; Amara M; Nebot N; Troché G; Breton N; Zuber B; Cavelot S; Pangon B; Bedos JP; Merrer J; Grimaldi D
    J Hosp Infect; 2018 Nov; 100(3):e105-e114. PubMed ID: 29857026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem nonsusceptibility with modified
    Choudhury D; Talukdar AD; Choudhury MD; Maurya AP; Chanda DD; Chakravorty A; Bhattacharjee A
    Indian J Med Microbiol; 2017; 35(1):137-139. PubMed ID: 28303836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
    Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
    FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Risk International Clones of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Endemic to Indonesian Intensive Care Units: Impact of a Multifaceted Infection Control Intervention Analyzed at the Genomic Level.
    Pelegrin AC; Saharman YR; Griffon A; Palmieri M; Mirande C; Karuniawati A; Sedono R; Aditianingsih D; Goessens WHF; van Belkum A; Verbrugh HA; Klaassen CHW; Severin JA
    mBio; 2019 Nov; 10(6):. PubMed ID: 31719179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
    J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    Shu JC; Kuo AJ; Su LH; Liu TP; Lee MH; Su IN; Wu TL
    J Antimicrob Chemother; 2017 Sep; 72(9):2489-2495. PubMed ID: 28535274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.
    Skurnik D; Roux D; Cattoir V; Danilchanka O; Lu X; Yoder-Himes DR; Han K; Guillard T; Jiang D; Gaultier C; Guerin F; Aschard H; Leclercq R; Mekalanos JJ; Lory S; Pier GB
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20747-52. PubMed ID: 24248354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant
    Stanton RA; Campbell D; McAllister GA; Breaker E; Adamczyk M; Daniels JB; Lutgring JD; Karlsson M; Schutz K; Jacob JT; Wilson LE; Vaeth E; Li L; Lynfield R; Snippes Vagnone PM; Phipps EC; Hancock EB; Dumyati G; Tsay R; Cassidy PM; Mounsey J; Grass JE; Bulens SN; Walters MS; Halpin AL
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0049622. PubMed ID: 36066241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology and carbapenem resistance of
    Khalili Y; Memar MY; Farajnia S; Adibkia K; Kafil HS; Ghotaslou R
    J Wound Care; 2021 Feb; 30(2):135-141. PubMed ID: 33573489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of β-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    Jahan MI; Rahaman MM; Hossain MA; Sultana M
    J Antimicrob Chemother; 2020 Jan; 75(1):86-91. PubMed ID: 31647552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
    Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
    Zhang JF; Chen BL; Xin XY; Zhao HB; Wang HY; Song H; Xu ZK
    Microb Drug Resist; 2009 Mar; 15(1):41-5. PubMed ID: 19226194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa isolated from four medical centres in Iran.
    Khalili Y; Omidnia P; Goli HR; Zamanlou S; Babaie F; Zahedi Bialvaei A; Esmailkhani A
    Mol Biol Rep; 2022 Sep; 49(9):8281-8289. PubMed ID: 35657451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis for the OprD gene among Pseudomonas aueroginosa clinical isolates obtained from hospitals in Jordan.
    Abu Khadra KM; Al-Rabaia SY; Khalil AM; Abu-Qatouseh LF; Abussaud MJ
    J Infect Dev Ctries; 2022 Apr; 16(4):683-690. PubMed ID: 35544631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.